Robert E. Gagnon

Insider · Chief Financial Officer · IRD

Robert E. Gagnon files insider transactions with the SEC as a chief financial officer of Opus Genetics (IRD). We hold 3 disclosed purchases and sales filed since 3 December 2010, 2 of them in the last 90 days.

Files forIRD
Disclosed buys and sells3 in all, 2 in the last 90 days
Last disclosure8 September 2026

Positions held

6 posts we hold — a term names its own dates; a run of filings only says when they filed

Filed 2 September 2025 — 3 September 2026Chief Financial Officer · Opus Genetics (IRD)7 Form 4 lines · source: SEC Form 4
Filed 18 November 2013 — 9 June 2026Chief Financial Officer · Harvard Bioscience (HBIO)58 Form 4 lines · source: SEC Form 4
Filed 28 August 2018 — 16 December 2025Chief Financial Officer · Verastem (VSTM)52 Form 4 lines · source: SEC Form 4
Filed 8 January 2024 — 4 June 2025Director · Bone Biologics (BBLG)4 Form 4 lines · source: SEC Form 4
Filed 11 September 2012 — 11 September 2012EVP CFO and Treasurer · Clean Harbors (CLH)3 Form 4 lines · source: SEC Form 4
Filed 1 December 2010 — 29 February 2012Vice President, Finance · Biogen Idec (BIIB)60 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

▼ sold on the open market 28,000 shares of Opus GeneticsSEC Form 48 September 2026Common Stock · traded 3 September 2026 · filed 8 September 2026
▼ sold on the open market 7,783 shares of Opus GeneticsSEC Form 427 July 2026Common Stock · traded 23 July 2026 · filed 27 July 2026
was granted 16,556 shares of Harvard BioscienceSEC Form 411 June 2026Common Stock · traded 9 June 2026 · filed 11 June 2026
▼ sold on the open market 7,842 shares of Opus GeneticsSEC Form 427 April 2026Common Stock · traded 23 April 2026 · filed 27 April 2026
was granted 400,000 shares of Opus GeneticsSEC Form 426 January 2026Common Stock · traded 22 January 2026 · filed 26 January 2026
was granted 400,000 shares of Opus GeneticsSEC Form 426 January 2026Common Stock · traded 22 January 2026 · filed 26 January 2026
▼ sold on the open market 283 shares of VerastemSEC Form 418 December 2025Common Stock · traded 16 December 2025 · filed 18 December 2025
▼ sold on the open market 281 shares of VerastemSEC Form 418 September 2025Common Stock · traded 16 September 2025 · filed 18 September 2025
was granted 250,000 shares of Opus Genetics (a derivative holding)SEC Form 411 September 2025Employee Stock Option (right to buy) · traded 2 September 2025 · filed 11 September 2025
was granted 200,000 shares of Opus GeneticsSEC Form 411 September 2025Common Stock · traded 10 September 2025 · filed 11 September 2025
was granted 110,000 shares of Harvard BioscienceSEC Form 418 July 2025Common Stock · traded 16 July 2025 · filed 18 July 2025
▼ sold on the open market 284 shares of VerastemSEC Form 420 June 2025Common Stock · traded 16 June 2025 · filed 20 June 2025
was granted 62,894 shares of Bone Biologics (a derivative holding)SEC Form 46 June 2025Non-Employee Stock Option · traded 4 June 2025 · filed 6 June 2025
was granted 12,500 shares of Verastem (a derivative holding)SEC Form 427 May 2025Stock Option (right to buy) · traded 22 May 2025 · filed 27 May 2025
was granted 8,333 shares of VerastemSEC Form 427 May 2025Common Stock · traded 22 May 2025 · filed 27 May 2025
▼ sold on the open market 284 shares of VerastemSEC Form 419 March 2025Common Stock · traded 17 March 2025 · filed 19 March 2025
▼ sold on the open market 285 shares of VerastemSEC Form 420 December 2024Common Stock · traded 16 December 2024 · filed 20 December 2024
▼ sold on the open market 130 shares of VerastemSEC Form 420 December 2024Common Stock · traded 19 December 2024 · filed 20 December 2024
▼ sold on the open market 131 shares of VerastemSEC Form 420 September 2024Common Stock · traded 19 September 2024 · filed 20 September 2024
was granted 30,713 shares of Bone Biologics (a derivative holding)SEC Form 419 September 2024Non- Employee Stock Option · traded 17 September 2024 · filed 19 September 2024
▼ sold on the open market 287 shares of VerastemSEC Form 418 September 2024Common Stock · traded 16 September 2024 · filed 18 September 2024
was granted 12,500 shares of Verastem (a derivative holding)SEC Form 420 June 2024Stock Option (right to buy) · traded 18 June 2024 · filed 20 June 2024
▼ sold on the open market 283 shares of VerastemSEC Form 420 June 2024Common Stock · traded 17 June 2024 · filed 20 June 2024
was granted 8,333 shares of VerastemSEC Form 420 June 2024Common Stock · traded 18 June 2024 · filed 20 June 2024
▼ sold on the open market 131 shares of VerastemSEC Form 420 June 2024Common Stock · traded 20 June 2024 · filed 20 June 2024
▼ sold on the open market 283 shares of VerastemSEC Form 420 March 2024Common Stock · traded 18 March 2024 · filed 20 March 2024
▼ sold on the open market 130 shares of VerastemSEC Form 420 March 2024Common Stock · traded 19 March 2024 · filed 20 March 2024
▼ sold on the open market 9,204 shares of VerastemSEC Form 47 February 2024Common Stock · traded 6 February 2024 · filed 7 February 2024
▼ sold on the open market 9,204 shares of VerastemSEC Form 417 January 2024Common Stock · traded 12 January 2024 · filed 17 January 2024
was granted 9 shares of Bone Biologics (a derivative holding)SEC Form 410 January 2024Non-Employee Stock Option · traded 8 January 2024 · filed 10 January 2024
was granted 8 shares of Bone Biologics (a derivative holding)SEC Form 410 January 2024Non-Employee Stock Option · traded 8 January 2024 · filed 10 January 2024
▼ sold on the open market 284 shares of VerastemSEC Form 420 December 2023Common Stock · traded 18 December 2023 · filed 20 December 2023
▼ sold on the open market 130 shares of VerastemSEC Form 420 December 2023Common Stock · traded 19 December 2023 · filed 20 December 2023
▼ sold on the open market 278 shares of VerastemSEC Form 420 September 2023Common Stock · traded 18 September 2023 · filed 20 September 2023
▼ sold on the open market 130 shares of VerastemSEC Form 420 September 2023Common Stock · traded 19 September 2023 · filed 20 September 2023
▼ sold on the open market 283 shares of VerastemSEC Form 421 June 2023Common Stock · traded 16 June 2023 · filed 21 June 2023
▼ sold on the open market 130 shares of VerastemSEC Form 421 June 2023Common Stock · traded 20 June 2023 · filed 21 June 2023
was granted 62,500 shares of Verastem (a derivative holding)SEC Form 416 May 2023Stock Option (right to buy) · traded 15 May 2023 · filed 16 May 2023
▼ sold on the open market 3,654 shares of VerastemSEC Form 420 March 2023Common Stock · traded 16 March 2023 · filed 20 March 2023
▼ sold on the open market 1,664 shares of VerastemSEC Form 420 March 2023Common Stock · traded 20 March 2023 · filed 20 March 2023
▼ sold on the open market 12,408 shares of VerastemSEC Form 420 December 2022Common Stock · traded 16 December 2022 · filed 20 December 2022
▼ sold on the open market 1,429 shares of VerastemSEC Form 420 December 2022Common Stock · traded 19 December 2022 · filed 20 December 2022
was granted 153,938 shares of Verastem (a derivative holding)SEC Form 415 December 2022Stock Option (right to buy) · traded 13 December 2022 · filed 15 December 2022
▼ sold on the open market 1,348 shares of VerastemSEC Form 421 September 2022Common Stock · traded 19 September 2022 · filed 21 September 2022
▼ sold on the open market 1,351 shares of VerastemSEC Form 422 June 2022Common Stock · traded 21 June 2022 · filed 22 June 2022
was granted 50,000 shares of VerastemSEC Form 417 May 2022Common Stock · traded 14 May 2022 · filed 17 May 2022
▼ sold on the open market 16,627 shares of VerastemSEC Form 417 May 2022Common Stock · traded 16 May 2022 · filed 17 May 2022
▼ sold on the open market 1,409 shares of VerastemSEC Form 423 March 2022Common Stock · traded 21 March 2022 · filed 23 March 2022
▼ sold on the open market 19,612 shares of VerastemSEC Form 45 January 2022Common Stock · traded 3 January 2022 · filed 5 January 2022
▼ sold on the open market 5,497 shares of VerastemSEC Form 422 December 2021Common Stock · traded 20 December 2021 · filed 22 December 2021
was granted 301,500 shares of Verastem (a derivative holding)SEC Form 417 December 2021Stock Option (Right to Buy) · traded 15 December 2021 · filed 17 December 2021
had shares withheld for tax on 45,329 shares of VerastemSEC Form 417 December 2021Common Stock · traded 12 August 2021 · filed 17 December 2021
was granted 148,500 shares of VerastemSEC Form 417 December 2021Common Stock · traded 15 December 2021 · filed 17 December 2021
was granted 203,776 shares of Verastem (a derivative holding)SEC Form 422 December 2020Stock Option (Right to Buy) · traded 18 December 2020 · filed 22 December 2020
was granted 67,925 shares of VerastemSEC Form 422 December 2020Common Stock · traded 18 December 2020 · filed 22 December 2020
was granted 290,210 shares of VerastemSEC Form 413 August 2020Common Stock · traded 11 August 2020 · filed 13 August 2020
was granted 62,500 shares of VerastemSEC Form 430 March 2020Common Stock · traded 27 March 2020 · filed 30 March 2020
was granted 125,000 shares of Verastem (a derivative holding)SEC Form 417 December 2019Stock Option (Right to Buy) · traded 13 December 2019 · filed 17 December 2019
was granted 125,000 shares of Verastem (a derivative holding)SEC Form 417 December 2019Stock Option (Right to Buy) · traded 13 December 2019 · filed 17 December 2019
was granted 250,000 shares of Verastem (a derivative holding)SEC Form 425 June 2019Stock Option (Right to Buy) · traded 21 June 2019 · filed 25 June 2019
was granted 100,000 shares of VerastemSEC Form 425 June 2019Common Stock · traded 21 June 2019 · filed 25 June 2019
was granted 50,000 shares of Verastem (a derivative holding)SEC Form 47 January 2019Stock Option (Right to Buy) · traded 3 January 2019 · filed 7 January 2019
was granted 50,000 shares of Verastem (a derivative holding)SEC Form 47 January 2019Stock Option (Right to Buy) · traded 3 January 2019 · filed 7 January 2019
was granted 350,000 shares of Verastem (a derivative holding)SEC Form 430 August 2018Stock Option (Right to Buy) · traded 28 August 2018 · filed 30 August 2018
was granted 50,000 shares of VerastemSEC Form 430 August 2018Common Stock · traded 28 August 2018 · filed 30 August 2018
▼ sold on the open market 8,889 shares of Harvard BioscienceSEC Form 430 August 2018Common Stock · traded 29 August 2018 · filed 30 August 2018
had shares withheld for tax on 5,170 shares of Harvard BioscienceSEC Form 413 August 2018Common Stock · traded 3 August 2018 · filed 13 August 2018
exercised options over 30,000 shares of Harvard BioscienceSEC Form 49 August 2018Common Stock · traded 7 August 2018 · filed 9 August 2018
exercised options over 20,000 shares of Harvard BioscienceSEC Form 49 August 2018Common Stock · traded 7 August 2018 · filed 9 August 2018
exercised options over 37,500 shares of Harvard BioscienceSEC Form 49 August 2018Common Stock · traded 7 August 2018 · filed 9 August 2018
▼ sold on the open market 100,015 shares of Harvard BioscienceSEC Form 49 August 2018Common Stock · traded 7 August 2018 · filed 9 August 2018
exercised options over 30,000 shares of Harvard Bioscience (a derivative holding)SEC Form 49 August 2018Stock option (right to buy) · traded 7 August 2018 · filed 9 August 2018
exercised options over 20,000 shares of Harvard Bioscience (a derivative holding)SEC Form 49 August 2018Stock option (right to buy) · traded 7 August 2018 · filed 9 August 2018
exercised options over 37,500 shares of Harvard Bioscience (a derivative holding)SEC Form 49 August 2018Stock option (right to buy) · traded 7 August 2018 · filed 9 August 2018
exercised options over 30,000 shares of Harvard Bioscience (a derivative holding)SEC Form 431 July 2018Stock option (right to buy) · traded 27 July 2018 · filed 31 July 2018
exercised options over 20,000 shares of Harvard Bioscience (a derivative holding)SEC Form 431 July 2018Stock option (right to buy) · traded 27 July 2018 · filed 31 July 2018
exercised options over 30,000 shares of Harvard BioscienceSEC Form 431 July 2018Common Stock · traded 27 July 2018 · filed 31 July 2018
exercised options over 20,000 shares of Harvard BioscienceSEC Form 431 July 2018Common Stock · traded 27 July 2018 · filed 31 July 2018
▼ sold on the open market 62,514 shares of Harvard BioscienceSEC Form 431 July 2018Common Stock · traded 27 July 2018 · filed 31 July 2018
▼ sold on the open market 5,570 shares of Harvard BioscienceSEC Form 426 July 2018Common Stock · traded 24 July 2018 · filed 26 July 2018
▼ sold on the open market 1,100 shares of Harvard BioscienceSEC Form 423 July 2018Common Stock · traded 19 July 2018 · filed 23 July 2018
▼ sold on the open market 1,465 shares of Harvard BioscienceSEC Form 423 July 2018Common Stock · traded 23 July 2018 · filed 23 July 2018
exercised options over 5,828 shares of Harvard Bioscience (a derivative holding)SEC Form 416 July 2018Stock option (right to buy) · traded 12 July 2018 · filed 16 July 2018
exercised options over 5,828 shares of Harvard BioscienceSEC Form 416 July 2018Common Stock · traded 12 July 2018 · filed 16 July 2018
▼ sold on the open market 9,145 shares of Harvard BioscienceSEC Form 416 July 2018Common Stock · traded 12 July 2018 · filed 16 July 2018
▼ sold on the open market 1,062 shares of Harvard BioscienceSEC Form 416 July 2018Common Stock · traded 13 July 2018 · filed 16 July 2018
exercised options over 14,200 shares of Harvard Bioscience (a derivative holding)SEC Form 411 July 2018Stock option (right to buy) · traded 9 July 2018 · filed 11 July 2018
exercised options over 13,700 shares of Harvard Bioscience (a derivative holding)SEC Form 411 July 2018Stock option (right to buy) · traded 10 July 2018 · filed 11 July 2018
exercised options over 62,100 shares of Harvard Bioscience (a derivative holding)SEC Form 411 July 2018stock option (right to buy) · traded 11 July 2018 · filed 11 July 2018
exercised options over 54,172 shares of Harvard Bioscience (a derivative holding)SEC Form 411 July 2018Stock option (right to buy) · traded 11 July 2018 · filed 11 July 2018
exercised options over 14,200 shares of Harvard BioscienceSEC Form 411 July 2018Common Stock · traded 9 July 2018 · filed 11 July 2018
▼ sold on the open market 14,200 shares of Harvard BioscienceSEC Form 411 July 2018Common Stock · traded 9 July 2018 · filed 11 July 2018
exercised options over 13,700 shares of Harvard BioscienceSEC Form 411 July 2018Common Stock · traded 10 July 2018 · filed 11 July 2018
▼ sold on the open market 13,700 shares of Harvard BioscienceSEC Form 411 July 2018Common Stock · traded 10 July 2018 · filed 11 July 2018
exercised options over 62,100 shares of Harvard BioscienceSEC Form 411 July 2018Common Stock · traded 11 July 2018 · filed 11 July 2018
exercised options over 54,172 shares of Harvard BioscienceSEC Form 411 July 2018Common Stock · traded 11 July 2018 · filed 11 July 2018
▼ sold on the open market 141,300 shares of Harvard BioscienceSEC Form 411 July 2018Common Stock · traded 11 July 2018 · filed 11 July 2018
was granted 40,000 shares of Harvard BioscienceSEC Form 429 May 2018Common Stock · traded 24 May 2018 · filed 29 May 2018
was granted 40,000 shares of Harvard BioscienceSEC Form 429 May 2018Common Stock · traded 24 May 2018 · filed 29 May 2018
had shares withheld for tax on 26,081 shares of Harvard BioscienceSEC Form 48 May 2018Common Stock · traded 6 May 2018 · filed 8 May 2018
▼ sold on the open market 97,087 shares of Harvard BioscienceSEC Form 412 March 2018Common Stock · traded 7 March 2018 · filed 12 March 2018
had shares withheld for tax on 20,048 shares of Harvard BioscienceSEC Form 44 January 2018Common Stock · traded 1 January 2018 · filed 4 January 2018
was granted 108,696 shares of Harvard BioscienceSEC Form 430 May 2017Common Stock · traded 25 May 2017 · filed 30 May 2017
was granted 108,696 shares of Harvard BioscienceSEC Form 430 May 2017Common Stock · traded 25 May 2017 · filed 30 May 2017
▲ bought on the open market 1,000 shares of Harvard BioscienceSEC Form 430 May 2017Common Stock · traded 26 May 2017 · filed 30 May 2017
had shares withheld for tax on 10,868 shares of Harvard BioscienceSEC Form 44 January 2017Common Stock · traded 1 January 2017 · filed 4 January 2017
▲ bought on the open market 5,000 shares of Harvard BioscienceSEC Form 43 November 2016Common Stock · traded 2 November 2016 · filed 3 November 2016
▲ bought on the open market 20,000 shares of Harvard BioscienceSEC Form 43 November 2016Common Stock · traded 3 November 2016 · filed 3 November 2016
was granted 88,652 shares of Harvard BioscienceSEC Form 410 May 2016Common Stock · traded 6 May 2016 · filed 10 May 2016
was granted 88,652 shares of Harvard BioscienceSEC Form 410 May 2016Common Stock · traded 6 May 2016 · filed 10 May 2016
had shares withheld for tax on 2,476 shares of Harvard BioscienceSEC Form 45 January 2016Common Stock · traded 1 January 2016 · filed 5 January 2016
▲ bought on the open market 1,500 shares of Harvard BioscienceSEC Form 416 November 2015Common Stock · traded 12 November 2015 · filed 16 November 2015
▲ bought on the open market 3,000 shares of Harvard BioscienceSEC Form 49 November 2015Common Stock · traded 9 November 2015 · filed 9 November 2015
was granted 28,117 shares of Harvard BioscienceSEC Form 45 August 2015Common Stock · traded 3 August 2015 · filed 5 August 2015
was granted 26,500 shares of Harvard BioscienceSEC Form 48 June 2015Common Stock · traded 4 June 2015 · filed 8 June 2015
was granted 50,000 shares of Harvard Bioscience (a derivative holding)SEC Form 48 June 2015Stock option (right to buy) · traded 4 June 2015 · filed 8 June 2015
acquired or disposed of, other 1,865 shares of Harvard BioscienceSEC Form 45 January 2015Common Stock · traded 31 December 2014 · filed 5 January 2015
acquired or disposed of, other 1,739 shares of Harvard BioscienceSEC Form 42 July 2014Common Stock · traded 30 June 2014 · filed 2 July 2014
▲ bought on the open market 5,000 shares of Harvard BioscienceSEC Form 416 June 2014Common Stock · traded 16 June 2014 · filed 16 June 2014
was granted 100,000 shares of Harvard Bioscience (a derivative holding)SEC Form 42 June 2014Stock option (right to buy) · traded 30 May 2014 · filed 2 June 2014

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.